Lung cancer is the leading cause of cancer death worldwide with an overall 5-year survival
rate of 18.1%. 1 Despite investigation of lung cancer genetics and improvements in …

The five-year survival rate of lung cancer patients is very low, mainly because most newly
diagnosed patients present with locally advanced or metastatic disease. Therefore, early …

Although there are new approaches in both cancer treatment and diagnosis, overall
mortality is a major concern. New technologies have attempted to look at breath volatile …

Lung cancer is the main cause of cancer incidence and mortality worldwide and the
identification of clinically useful biomarkers for lung cancer detection at both early and …

Low dose computed tomography (LDCT) screening, together with the recent advances in
targeted and immunotherapies, have shown to improve non-small cell lung cancer (NSCLC) …

Purpose KRAS is the most frequently mutated gene in human cancers. Despite its direct
involvement in malignancy and intensive effort, direct inhibition of KRAS via …

Lung cancer is the third most diagnosed cancer, but the first cause of cancer-related deaths
worldwide. This rather high death rate is due mainly to the fact that most patients are …

MicroRNAs (miRNAs) have been proven to regulate gene expression at the protein
translation level. miRNA abnormal expression has been associated with the development of …

This study represents a novel proof of concept of the clinical utility of miRNAs from exhaled
breath condensate (EBC) as biomarkers of lung cancer (LC). Genome-wide miRNA profiling …

Lung cancer (LC) is the leading cause of cancer-related deaths worldwide. On the other
hand, idiopathic pulmonary fibrosis (IPF) is the most common interstitial lung disease …